PHRX (Pharmagen) Accounts Payable: $1.73 Mil (As of Mar. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmagen Accounts Payable?

Pharmagen PHRX -90.00% Accounts Payable is $1.73 Mil as of Mar. 2014.

Pharmagen's Accounts Payable for the quarter that ended in Mar. 2014 was $1.73 Mil.

Pharmagen's quarterly Accounts Payable increased from Sep. 2013 ($1.02 Mil) to Dec. 2013 ($1.38 Mil) and increased from Dec. 2013 ($1.38 Mil) to Mar. 2014 ($1.73 Mil).

Pharmagen's annual Accounts Payable increased from Jun. 2011 ($0.04 Mil) to Dec. 2012 ($0.79 Mil) and increased from Dec. 2012 ($0.79 Mil) to Dec. 2013 ($1.38 Mil).

Pharmagen Accounts Payable Historical Data

* Premium members only.

The historical data trend for Pharmagen's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen Accounts Payable Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
Accounts Payable
0.02 0.04 0.79 1.38

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 0.88 1.02 1.38 1.73

Pharmagen Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.73 Mil mean?
Pharmagen (PHRX) has a Accounts Payable of $1.73 Mil as of Mar. 2014. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Pharmagen and its competitors.
Is Pharmagen's Accounts Payable too high?
Pharmagen's current Accounts Payable is $1.73 Mil.
How does Pharmagen's Accounts Payable compare to FZMD and SNYR?
Pharmagen's Accounts Payable of $1.73 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Distribution company?
A good Accounts Payable depends on the Medical Distribution industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Pharmagen and its competitors. Pharmagen's current Accounts Payable is $1.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current Accounts Payable of $1.73 Mil. The current Accounts Payable is $1.73 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Pharmagen (PHRX), the current Accounts Payable is $1.73 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.